undefined background

Used for

    Peptide drug designMolecular modelingTherapeutics developmentPharmaceutical researchBiotechnology innovation

Features

    Generative AI platformPhysics-based molecular modelingHigh accuracy peptide designIn silico to in vivo validationRapid drug design processHigh plasma stabilityCell-permeability and oral bioavailabilityLarge chemical space explorationEfficient data creationHigh in vitro hit successGenerative AI for peptide drug design.Physics-based molecular modeling.Overcomes limitations of traditional drug design.Creates novel, efficient drug-like chemical matter.High plasma stability in designed drugs.nM potency and cell-permeability.Rapid design process (8 weeks).10,000x greater sampling power than traditional methods.>50% in vitro hit success rate.Validated with multiple hit molecules across various drug targets.

What is Menten AI?

Menten AI is a platform that uses generative AI to design peptide therapeutics, combining physics-based design with machine learning to create novel drug molecules.

How does Menten AI differ from traditional drug design methods?

Menten AI overcomes traditional limitations by creating its own data from first principles, using machine learning to guide drug design with high accuracy and efficiency.

What are the advantages of using Menten AI for drug design?

Menten AI offers advantages like rapid design process, high plasma stability, nM potency, cell-permeability, and greater sampling power than traditional methods.

Who can benefit from using Menten AI?

Pharmaceutical researchers, biotechnologists, medicinal chemists, drug development scientists, and healthcare innovators can benefit from Menten AI.

Is Menten AI backed by any venture capitalists?

Yes, Menten AI is backed by top-tier venture capitalists including Uncork Capital, Khosla Ventures, Social Impact Capital, and Y-Combinator.

How successful is Menten AI in generating hit molecules?

Menten AI has a >50% in vitro hit success rate, significantly higher than the industry average of ~9%.

What specific drug properties does Menten AI achieve?

Menten AI achieves desirable drug properties such as high plasma stability, oral bioavailability, nM potency, and cell-permeability.

Can Menten AI design drugs for undruggable targets?

Yes, Menten AI is designed to target currently undruggable targets using its advanced generative AI platform.

How fast can Menten AI deliver drug-like hit molecules?

Menten AI can deliver drug-like hit molecules in a single round of design in just 8 weeks.

Has Menten AI been validated with real-world applications?

Yes, Menten AI has been validated with multiple hit molecules across various drug targets, including an anti-viral peptide for Covid-19.

Share this page

Quick Links

Frequently Asked Questions

Resources

Categories

Contact Us

Email

success@expify.ai
TwitterFacebook

Expify.AI 2024